The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
Open accessAbstract
Significance: The diabetes drugs metformin and phenformin have interesting anticancer properties including the selective inhibition of cancer stem cells (CSCs). We show that these drugs ( i ) have remarkably similar metabolic profiles, ( ii ) reduce the tricarboxylic acid cycle and selected glyolytic intermediates during transformation, providing physiological evidence that mitochondrial complex I is a target, and ( iii ) have very different effects during transformation and in CSCs. These observations provide insight into the metabolic effects of these drugs in cancer contexts and their selective effects in CSCs that underlie potential cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“MCF-10A ER-Src cells were grown as previously described in DMEM/F12 media supplemented with charcoal stripped FBS, penicillin/streptomycin, puromycin, EGF, hydrocortisone, insulin, and choleratoxin (1).”
MethodOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 3×
“The direct target(s) of metformin is unknown, although mitochondrial complex I is the best candidate at present (14, 20).”
BackgroundSoule, H. D., Maloney, T., Wolman, S. R., Peterson, W., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., & Brooks, S. C. (1990) · PubMed · Cited by 1,507
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
Self-citationHirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Self-citationMetformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967 · cited 1×
“Interestingly altered folate metabolism in the Escherichia coli food source has been implicated in metformin-mediated benefits in Caenorhabditis elegans (31).”
BackgroundJiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 3×
“Toxicol Appl Pharmacol 233(2):203–210.”
MethodInfluentialSIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782
Self-citationInfluence of Threonine Metabolism on S -Adenosylmethionine and Histone Methylation
Shyh-Chang, N., Locasale, J. W., Lyssiotis, C. A., Zheng, Y., Teo, R. Y., Ratanasirintrawoot, S., Zhang, J., Onder, T., Unternaehrer, J. J., Zhu, H., et al. (2013) · Science · doi:10.1126/science.1226603 · Cited by 638
Self-citationAlimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Pollak, M. N. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0263 · Cited by 507
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3471 · Cited by 450
Self-citationHirsch, H. A., Iliopoulos, D., & Struhl, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221055110 · Cited by 440 · cited 3×
“Transformation in the inducible ER-Src model is mediated by an inflammatory response that depends on NF-κB and STAT3 (9, 24), and metformin blocks this response by an unknown mechanism (15).”
BackgroundSelf-citationImportant role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K., Woods, Y. L., Mcburnie, W., Fleming, S., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080557 · Cited by 396
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Liu, B., Fan, Z., Edgerton, S. M., Deng, X.-S., Alimova, I. N., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8814 · Cited by 392
Laurent, G., German, N. J., Saha, A. K., de Boer, V. C. J., Davies, M., Koves, T. R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.012 · Cited by 391
Self-citationHirsch, H. A., Iliopoulos, D., Joshi, A., Zhang, Y., Jaeger, S. A., Bulyk, M., Tsichlis, P. N., Shirley Liu, X., & Struhl, K. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.022 · Cited by 359
Self-citationMetformin in cancer: translational challenges
Dowling, R. J. O., Niraula, S., Stambolic, V., & Goodwin, P. J. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0007 · Cited by 355
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Grimshaw, M. J., Cooper, L., Papazisis, K., Coleman, J. A., Bohnenkamp, H. R., Chiapero-Stanke, L., Taylor-Papadimitriou, J., & Burchell, J. M. (2008) · Breast Cancer Research · doi:10.1186/bcr2106 · Cited by 339
Dykens, J. A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P. A., & Will, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.013 · Cited by 220
Role of AMP‐activated protein kinase in the metabolic syndrome and in heart disease
Hardie, D. G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.018 · Cited by 217
Distinct perturbation of the translatome by the antidiabetic drug metformin
Larsson, O., Morita, M., Topisirovic, I., Alain, T., Blouin, M.-J., Pollak, M., & Sonenberg, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201689109 · Cited by 205
Fendt, S.-M., Bell, E. L., Keibler, M. A., Davidson, S. M., Wirth, G. J., Fiske, B., Mayers, J. R., Schwab, M., Bellinger, G., Csibi, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0080 · Cited by 199
Liao, M.-J., Zhang, C. C., Zhou, B., Zimonjic, D. B., Mani, S. A., Kaba, M., Gifford, A., Reinhardt, F., Popescu, N. C., Guo, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4493 · Cited by 182
Scotland, S., Saland, E., Skuli, N., de Toni, F., Boutzen, H., Micklow, E., Sénégas, I., Peyraud, R., Peyriga, L., Théodoro, F., et al. (2013) · Leukemia · doi:10.1038/leu.2013.107 · Cited by 163
Şahin, M., Tütüncü, N. B., Ertuğrul, D. T., Tanaci, N., & Guvener, N. D. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.10.005 · Cited by 154
Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells
Kim, S. A., & Choi, H. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.165 · Cited by 149
Corominas-Faja, B., Quirantes‐Piné, R., Oliveras‐Ferraros, C., Vázquez‐Martín, A., Cufí, S., Martín-Castillo, B., Micol, V., Joven, J., Segura‐Carretero, A., & Menéndez, J. A. (2012) · Aging · doi:10.18632/aging.100472 · Cited by 129
Phenformin as prophylaxis and therapy in breast cancer xenografts
Appleyard, M. V. C. L., Murray, K. E., Coates, P. J., Wullschleger, S., Bray, S. E., Kernohan, N. M., Fleming, S., Alessi, D. R., & Thompson, A. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.56 · Cited by 108
Li, S.-N., Wang, X., Zeng, Q.-T., Feng, Y.-B., Cheng, X., Mao, X.-B., Wang, T.-H., & Deng, H.-P. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1137-7 · Cited by 88
Rosilio, C., Lounnas, N., Nebout, M., Imbert, V., Hagenbeek, T. J., Spits, H., Asnafi, V., Pontier-Bres, R., Reverso, J., Michiels, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.015 · Cited by 71
Shitara, Y., Nakamichi, N., Norioka, M., Shima, H., Kato, Y., & Horie, T. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs330 · Cited by 47
Zakikhani, M., Bazile, M., Hashemi, S., Javeshghani, S., Avizonis, D. Z., St‐Pierre, J., & Pollak, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049513 · Cited by 40
Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells
Xu, Q., Vu, H., Liu, L., Wang, T., & Schaefer, W. H. (2011) · Journal of Biomolecular NMR · doi:10.1007/s10858-011-9482-8 · Cited by 37
Basu, S. S., & Blair, I. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200366j · Cited by 32
Cited by
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
“Cancer-initiating cells also have increased sensitivity to mitochondrial inhibitors, adding further evidence that inhibiting mitochondrial metabolism may suppress tumor recurrence (177, 178).”
BackgroundUnderstanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Targeting mitochondria metabolism for cancer therapy
Weinberg, S. E., & Chandel, N. S. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1712 · Cited by 1,381
ROS homeostasis and metabolism: a dangerous liason in cancer cells
Panieri, E., & Santoro, M. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.105 · Cited by 1,151
Metadata
- Authors
- Janzer, A., German, N. J., Gonzalez-Herrera, K. N., Asara, J. M., Haigis, M. C., & Struhl, K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-07-07
- Volume
- 111
- Issue
- 29
- Pages
- 10574-10579
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2061059838
- Cited by
- 265
- References
- 40
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.